Also known as: Tomudex; ZD1694; ICI D1694
Raltitrexed is a specific thymidylate synthase (TS) inhibitor used in the treatment of advanced colorectal cancer. It is a folate analogue that inhibits DNA synthesis. Mediocon Inc manufactures GMP-compliant Raltitrexed at its Aurangabad facility to international pharmacopoeial standards.
| Parameter | Specification |
|---|---|
| CAS Number | 112887-68-0 |
| Molecular Formula | C₂₁H₂₂N₄O₆S |
| Molecular Weight | 458.49 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Thymidylate Synthase Inhibitor / Antineoplastic |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | RLT/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Raltitrexed — CAS 112887-68-0 (CAS 112887-68-0) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Raltitrexed — CAS 112887-68-0 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance